E
Xilio Therapeutics, Inc. XLO
$0.6998 -$0.0182-2.54% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 8.08M 2.93M 1.72M 2.26M 2.36M
Total Other Revenue -- -- -- -- --
Total Revenue 8.08M 2.93M 1.72M 2.26M 2.36M
Cost of Revenue 15.33M -- -- -- 11.22M
Gross Profit -7.25M 2.93M 1.72M 2.26M -8.86M
SG&A Expenses 7.12M 8.52M 6.52M 6.31M 5.82M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 22.45M 16.78M 15.35M 17.07M 17.03M
Operating Income -14.37M -13.85M -13.63M -14.80M -14.67M
Income Before Tax -15.84M -13.27M -13.09M -14.02M -13.93M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -15.84M -13.27M -13.09M -14.02M -13.93M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -15.84M -13.27M -13.09M -14.02M -13.93M
EBIT -14.37M -13.85M -13.63M -14.80M -14.67M
EBITDA -13.99M -13.35M -13.25M -14.42M -14.23M
EPS Basic -0.31 -0.18 -0.20 -0.22 -0.32
Normalized Basic EPS -0.19 -0.11 -0.13 -0.14 -0.20
EPS Diluted -0.31 -0.18 -0.20 -0.22 -0.32
Normalized Diluted EPS -0.19 -0.11 -0.13 -0.14 -0.20
Average Basic Shares Outstanding 51.83M 74.70M 64.68M 63.47M 43.95M
Average Diluted Shares Outstanding 51.83M 74.70M 64.68M 63.47M 43.95M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --